🔗 Permalink

Inventor profile of:

Robert Zamboni

City:

Beaconsfield

Country:

Canada

Published Applications:

Last publication date:

2025-11-06

Top Assignees for applications by Robert Zamboni

The entities that hold a legal rights for patent applications filed by inventor Zamboni Robert:

AEROMICS, INC. 6 New Haven, CT United States
Aeromics, Inc. 3 Cleveland, OH United States
ST. JUDE CHILDREN'S RESEARCH HOSPITAL INC. 2 Memphis, TN United States
Affinium Pharmaceuticals, Inc. 1 Toronto, Canada
Amgen Inc. 1 Thousand Oaks, CA United States
CANTERO THERAPEUTICS, INC. 1 Palo Alto, CA United States
COA THERAPEUTICS, INC. 1 San Francisco, CA United States
ZAMBONI CHEM SOLUTIONS INC. 1 Beaconsfiel, Quebec, Canada
COA THERAPEUTICS, INC. 1 Palo Alto, CA United States
COSMAS THERAPEUTICS DEVELOPMENT INC. 1 MONTREAL, QC Canada
Debiopharm International SA 1 Lausanne, Switzerland

Recent patent applications by Zamboni Robert

Robert Zamboni from Beaconsfield, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-06

US20250339396A1

Human necessities

NOVEL MODULATORS OF THE MELATONIN RECEPTORS AS WELL AS METHOD OF MANUFACTURE AND USES THEREOF

#2 | 2025-07-03

US20250213571A1

Human necessities

TYK2 INHIBITORS AND USES THEREOF

#3 | 2025-06-26

US20250206765A1

Chemistry; metallurgy

CRYSTALS

#4 | 2025-06-12

US20250188093A1

Chemistry; metallurgy

TYK2 INHIBITORS AND USES THEREOF

#5 | 2025-03-20

US20250090526A1

Human necessities

METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR

#6 | 2024-08-29

US20240287039A1

Chemistry; metallurgy

SMALL MOLECULE MODULATORS OF PANTOTHENATE KINASES

#7 | 2024-05-23

US20240166673A1

Chemistry; metallurgy

Crystals

#8 | 2023-10-12

US20230321092A1

Human necessities

METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR

#9 | 2023-05-11

US20230143491A1

Chemistry; metallurgy

TRIAZOLE GLYCOLATE OXIDASE INHIBITORS

#10 | 2022-06-30

US20220204536A1

Chemistry; metallurgy

Crystals

#11 | 2022-05-12

US20220143048A1

Human necessities

Prodrug salts

#12 | 2021-12-30

US20210403439A1

Chemistry; metallurgy

Triazole glycolate oxidase inhibitors

#13 | 2021-03-04

US20210061788A1

Chemistry; metallurgy

Small molecule modulators of pantothenate kinases

#14 | 2021-01-28

US20210023081A1

Human necessities

Methods of treating disorders associated with castor

#15 | 2020-09-24

US20200297740A1

Human necessities

Prodrug salts

#16 | 2019-06-20

US20190185496A1

Chemistry; metallurgy

Crystals

#17 | 2019-04-04

US20190100534A1

Chemistry; metallurgy

Cephem Compounds with Latent Reactive Groups

#18 | 2018-12-06

US20180346457A1

Chemistry; metallurgy

RAF-degrading conjugate compounds

#19 | 2018-06-21

US20180169118A1

Human necessities

Prodrug salts

#20 | 2016-09-15

US20160264604A1

Chemistry; metallurgy

Prodrug salts

#21 | 2014-02-20

US20140051666A1

Chemistry; metallurgy

Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide

#22 | 2009-04-16

US20090099173A1

Chemistry; metallurgy

Pyridopyridazine compounds, compositions and methods of use

InventorID:

659091 ⎘